Fidelity Investments
ABEO icon

Fidelity Investments’s Abeona Therapeutics ABEO Stock Holding History

Fidelity Investments’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$856K Sell
138,497
-56,316
-29% -$309K ﹤0.01% 3068
2026
Q1 		$873K Buy
194,813
+26,358
+16% +$132K ﹤0.01% 2924
2025
Q4 		$888K Buy
168,455
+162,671
+2,812% +$819K ﹤0.01% 2895
2025
Q3 		$30.5K Sell
5,784
-1,296
-18% -$8.22K ﹤0.01% 4181
2025
Q2 		$40.2K Buy
+7,080
New +$40.3K ﹤0.01% 3995
2024
Q2 		– Sell
-40
Closed -$290 – 5347
2024
Q1 		$290 Buy
+40
New +$253 ﹤0.01% 4891
2023
Q3 		– Sell
-16
Closed -$64 – 5266
2023
Q2 		$64 Buy
+16
New +$56 ﹤0.01% 4996
2019
Q4 		– Sell
-29,367
Closed -$1.66M – 3737
2019
Q3 		$1.66M Sell
29,367
-140,077
-83% -$10.5M ﹤0.01% 2311
2019
Q2 		$20.2M Sell
169,444
-118,171
-41% -$19.8M ﹤0.01% 1618
2019
Q1 		$52.9M Sell
287,615
-52
-0% -$9.3K 0.01% 1191
2018
Q4 		$51.3M Buy
287,667
+7
+0% +$1.53K 0.01% 1123
2018
Q3 		$92.1M Buy
287,660
+3,888
+1% +$1.38M 0.01% 988
2018
Q2 		$114M Buy
283,772
+91,640
+48% +$40M 0.01% 893
2018
Q1 		$68.9M Buy
192,132
+35,988
+23% +$13.4M 0.01% 1150
2017
Q4 		$61.9M Buy
+156,144
New +$64.6M 0.01% 1196

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OIA
OneDigital Investment Advisors Overland Park, Kansas $11.8B AUM 21.23% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fidelity Investments's ABEO Position: Q2 2026 in Review

Fidelity Investments reduced its Abeona Therapeutics (ABEO) stake by 29% in Q2 2026, selling an estimated $309K and leaving 138,497 shares worth $856K. The position accounts for ﹤0.01% of the portfolio, ranked #3068.

Fidelity Investments first reported a position in ABEO in Q4 2017 and has held it in 15 quarters since. The position peaked at $114M in Q2 2018. 127 funds tracked by Wall St. Rank hold ABEO as of Q2 2026.

  • Fidelity Investments held 138,497 shares of Abeona Therapeutics worth $856K as of Q2 2026.
  • Fidelity Investments sold 56,316 Abeona Therapeutics shares in Q2 2026, an estimated $309K.
  • Abeona Therapeutics made up ﹤0.01% of Fidelity Investments's portfolio in Q2 2026, its #3068 holding.
  • Fidelity Investments first reported a position in Abeona Therapeutics in Q4 2017 and has held it in 15 quarters since.
  • Fidelity Investments's Abeona Therapeutics position peaked at $114M in Q2 2018.
  • 127 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2026.

Based on Fidelity Investments's 13F filing for Q2 2026, filed 13 Aug 2026.